Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does SECUKINUMAB Cause Alanine aminotransferase increased? 413 Reports in FDA Database

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

According to the FDA Adverse Event Reporting System (FAERS), 413 reports of Alanine aminotransferase increased have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.3% of all adverse event reports for SECUKINUMAB.

413
Reports of Alanine aminotransferase increased with SECUKINUMAB
0.3%
of all SECUKINUMAB reports
2
Deaths
147
Hospitalizations

How Dangerous Is Alanine aminotransferase increased From SECUKINUMAB?

Of the 413 reports, 2 (0.5%) resulted in death, 147 (35.6%) required hospitalization, and 7 (1.7%) were considered life-threatening.

Is Alanine aminotransferase increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 413 reports have been filed with the FAERS database.

What Other Side Effects Does SECUKINUMAB Cause?

Drug ineffective (27,434) Psoriasis (21,976) Pain (15,244) Arthralgia (13,769) Fatigue (9,406) Psoriatic arthropathy (8,900) Pruritus (8,755) Malaise (8,570) Rash (8,023) Condition aggravated (7,536)

What Other Drugs Cause Alanine aminotransferase increased?

METHOTREXATE (2,440) RITUXIMAB (1,651) ADALIMUMAB (1,308) TOCILIZUMAB (1,163) ETANERCEPT (1,131) LEFLUNOMIDE (1,099) ACETAMINOPHEN (1,083) REMDESIVIR (1,047) FINGOLIMOD (1,020) INFLIXIMAB (981)

Which SECUKINUMAB Alternatives Have Lower Alanine aminotransferase increased Risk?

SECUKINUMAB vs SELADELPAR LYSINE SECUKINUMAB vs SELEGILINE SECUKINUMAB vs SELENIUM SECUKINUMAB vs SELENIUM SULFIDE SECUKINUMAB vs SELEXIPAG

Related Pages

SECUKINUMAB Full Profile All Alanine aminotransferase increased Reports All Drugs Causing Alanine aminotransferase increased SECUKINUMAB Demographics